Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
ANRS, Emerging Infectious Diseases
🇫🇷
France
Country
🇫🇷
France
Ownership
Private
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis
Phase 3
Completed
Conditions
Carcinoma, Hepatocellular
Hepatitis, Viral, Human
Interventions
Drug: 131 I-lipiodol
Subscribe
First Posted Date
2005-06-30
Last Posted Date
2013-09-23
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
73
Registration Number
NCT00116454
Locations
🇫🇷
Service d'Hépatologie Hôpital Saint Antoine, Paris, France
Subscribe
Prev
1
16
17
18
19
20
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy